Arthritis and Rheumatology

Aims & Scope

Arthritis & Rheumatology, an official journal of the American College of Rheumatology, is a peer-reviewed publication for scientists and clinicians interested in the natural history, pathophysiology, treatment, and outcome of the rheumatic diseases.

Arthritis & Rheumatology publishes the highest quality basic and clinical research related to the rheumatic diseases, encompassing a wide range of areas of investigative activity.

In addition, the journal publishes review articles, editorials, and other educational material intended for both researchers and clinicians.

Serving the worldwide community of rheumatology investigators and clinicians, Arthritis & Rheumatology is known internationally as a top rheumatology research journal.

View Aims & Scope

---

Metrics & Ranking

Impact Factor

Year	Value
2025	10.9
2024	11.40

Journal Rank

Year	Value
2024	477

Journal Citation Indicator

Year	Value
2024	6627

SJR (SCImago Journal Rank)

Year	Value
2024	3.784

Quartile

Year	Value
2024	Q1

---

---

Abstracting & Indexing

Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.

• Scopus
• Google Scholar
• Web of Science
• Medline
• Embase

---

Subjects & Keywords

Journal’s research areas, covering key disciplines and specialized sub-topics in Immunology and Microbiology and Medicine, designed to support cutting-edge academic discovery.

---

Most Cited Articles

The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.

• 2019 European League Against Rheumatism/American College of Rheumatology Classification Criteria for Systemic Lupus Erythematosus

  Citation: 1709

  Authors: Martin, Karen, David, Ralph, Marta, Rosalind, Josef S., David, Dimitrios T., Diane L., David, Ricard, Nathalie, Betty, Dafna D., Bevra, Falk, Søren, Dinesh, Kirsten, Elena, Joseph, Guillermo, Jorge, Matthias, Murray, George, Bimba F., Nicolai, Chiara, Sara K., Zahi, Gabriela, Branimir, Florence, Tak Mao, Ann Elaine, Mary K., László, Andrea, Winfried, Bernadett, Sarfaraz, Peter M., Michelle, Gábor, Xavier, Ivan, José M., Juanita, Íñigo, Raphaèle, Georg H., Yoshiya, Maria G., Carlos, Edward M., Daniel J., Sule, Pier Luigi, Marvin J., Ray, Thomas, Sindhu R.

• 2015 American College of Rheumatology Guideline for the Treatment of Rheumatoid Arthritis

  Citation: 1426

  Authors: Jasvinder A., Kenneth G., S. Louis, Elie A., Raveendhara R., Matthew C., Elizaveta, Christine, Mikala, Robert H., Jeffrey R., Daniel E., Deborah, Arthur, James, Charles, Amye, Eric L., John T., Barbara, Seth, James, E. William, Elizabeth, Amy S., Timothy

• 2016 American College of Rheumatology/European League Against Rheumatism Classification Criteria for Primary Sjögren's Syndrome: A Consensus and Data‐Driven Methodology Involving Three International Patient Cohorts

  Citation: 1337

  Authors: Caroline H., Stephen C., Raphaèle, Lindsey A., Marc, Thomas M., Astrid, Hal, Claudio, Simon J., Xavier

• 2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee

  Citation: 1329

  Authors: Sharon L., Tuhina, Marc C., Carol, Gordon, Joel, Leigh, Cindy, Carole, David, Kathleen, William F., Gillian, Edward, C. Kent, Amanda E., Jonathan, Carla, Daniel, Barton, Roy D., Dana, Joann, Gina, Mariko, Devyani, Amit Aakash, Anna K., Louise M., Marat, Amy S., James

• Development and Validation of the HScore, a Score for the Diagnosis of Reactive Hemophagocytic Syndrome

  Citation: 1071

  Authors: Laurence, Lionel, Olivier, Christophe, Cedric, Doumit, Paul, Gilles

• Contemporary Prevalence of Gout and Hyperuricemia in the United States and Decadal Trends: The National Health and Nutrition Examination Survey, 2007–2016

  Citation: 828

  Authors: Michael, Chio, Sharan K., Michael H., Hyon K.

• International Consensus Guidance Statement on the Management and Treatment of IgG4‐Related Disease

  Citation: 826

  Authors: A., Z. S., J. L., T., A., M. N., S. T., E., L., H., P. A., T., S., M., M. H., Y., K., M. M., M., Y., S., T., S., T., H., K., J.H., T., N., A., T., H., M., A., M., H., G. J., T. E., M., W., T., J. H.

• Prevalence Trends of Site‐Specific Osteoarthritis From 1990 to 2019: Findings From the Global Burden of Disease Study 2019

  Citation: 798

  Authors: Huibin, Qiang, Heyong, Kai, Naicheng, Yuqing, Jianhao, Ai

• Group for Research and Assessment of Psoriasis and Psoriatic Arthritis 2015 Treatment Recommendations for Psoriatic Arthritis

  Citation: 735

  Authors: Laura C., Arthur, Philip J., Enrique R., Maria, April W., Wilson, Wolf‐Henning, Willemina, Alberto, Luis R., Oliver, Dafna D., Alice, Philip S., M. Elaine, Thorvardur J., Ennio, Neil, Peter, Alexis, Ana‐Maria, Andrew, Denis, Cheryl F., Sergio, Evan L., Sergio, William, Christopher T.

• Anifrolumab, an Anti–Interferon‐α Receptor Monoclonal Antibody, in Moderate‐to‐Severe Systemic Lupus Erythematosus

  Citation: 707

  Authors: Richard, Munther, Joan T., Victoria P., Kenneth, Philip, Gabor G., Jorn, Liangwei, Stephen

---